Table 3 The parameters for the computation of HQ, HI, RI and CR.
Heavy metal (HM) | Cd | Cr | Cu | Fe | Hg | Mn | Ni | Pb | Sr | Zn | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|
Oral reference dose. RfD oral (mg/kg/day) | 0.0005 | 0.003 | 0.04 | 0.7 | 0.0003 | 0.024 | 0.02 | 0.0014 | 0.6 | 0.3 | |
Dermal reference dose. Rfd Dermal (mg/kg/day) | 0.000025 | 0.000075 | 0.012 | 0.14 | 0.000021 | 0.00096 | 0.0008 | 0.00042 | 0.12 | 0.06 | |
Dermal absorption fraction. ABS | 0.05 | 0.025 | 0.3 | 0.2 | 0.07 | 0.04 | 0.04 | 0.3 | 0.2 | 0.2 | |
Permeability Coefficient. Kp | 0.001 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0.0002 | 0.0001 | 0.001 | 0.0006 | |
Oral cancer slope factor. CSFing mg/kg/day | 6.1 | 0.5 | 0.5 | ||||||||
Dermal cancer slope factor. CSFder | 6100 | 500 | 500 | ||||||||
Toxic response factor. Tr values | 30 | 2 | 5 | 1 | 40 | 1 | 5 | 5 | 1 | 1 | |
Background value ppm. Cbg | 0.2 | 35 | 55 | 15,000 | 0.8 | 600 | 20 | 12.5 | 350 | 70 |